Altium Capital Management LP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
Altium Capital Management LP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$11,505,750
+25.7%
725,000
+49.5%
6.00%
-13.4%
Q2 2023$9,151,950
+626.3%
485,000
+73.2%
6.93%
+1274.4%
Q2 2022$1,260,000
-71.2%
280,000
-69.6%
0.50%
-65.6%
Q1 2022$4,379,000920,0001.46%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 3,984,734$15,421,0001.00%
Moloney Securities Asset Management, LLC 274,450$1,062,0000.55%
Schonfeld Strategic Advisors LLC 1,025,176$3,968,0000.40%
Orbimed Advisors 6,095,647$23,590,0000.27%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$438,0000.26%
PINNACLE ASSOCIATES LTD 1,589,959$6,153,0000.12%
Baker Brothers Advisors 3,015,353$11,669,0000.10%
BAXTER BROS INC 58,000$224,0000.07%
SIMON QUICK ADVISORS, LLC 25,000$97,0000.06%
ClearBridge Investments 14,428,856$55,840,0000.06%
View complete list of IMMUNOGEN INC shareholders